Flometoquin Patent Landscape Analysis

Flometoquin is an insecticide jointly developed by Nippon Kayaku and Meiji Seika, commercialised through the FineSave® brand.

The retained landscape covers 26 patent families across 16 consolidated owner groups. Two-active combination is the thickest protection layer (14 families), with manufacturing route and formulation claims providing additional constraint.

16 of the 26 retained families carry a grant or national pending reading. 11 families are held by China-based applicants. 1 live family has a nominal term ending within five years. Position as at November 2026.

This 36-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.